AirSculpt Technologies, Inc. (AIRS)
NasdaqGM · USD · Healthcare · Medical Care Facilities
$1.17 (-2.50%) as of
Key statistics
- Market cap
- 84.35M
- Forward P/E
- -117.00
- EPS (TTM)
- -0.1700
- Dividend yield
- 0.00%
- 52-week range
- 1.1500 – 11.9300
- Beta
- 2.33
- Revenue (TTM)
- 150.72M
- Profit margin
- -7.79%
- Analyst target
- $4.50
- Volume
- 279.89k
About AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Tampa, Florida.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Tampa, FL, United States
- Employees
- 330
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.